List of insiders holdings for Immunovant Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Roivant Sciences Ltd. Director 10% Owner | 2023-10-04 17:19:22 | 79,815,331 0 | 79,815,331 | Form 13D |
| WONG RODERICK Chief Executive Officer | 2020-04-09 17:13:05 | 4,426,106 0 | 4,426,106 | Form 13G |
| Salzmann Peter Chief Executive Officer | 2024-11-22 16:08:23 | 978,097 0 | 978,097 | Form 4 |
| Torti Frank Director | 2024-04-04 16:44:13 | 685,841 0 | 685,841 | Form 4 |
| Jain Rita Chief Medical Officer | 2021-03-31 12:37:19 | 471,665 0 | 471,665 | Form 4/A |
| Butchko Julia G. Chief Development Officer | 2024-08-23 16:10:20 | 440,959 0 | 440,959 | Form 4 |
| Elliott Michael James Chief Scientific Officer | 2021-03-23 08:43:18 | 439,900 0 | 439,900 | Form 4 |
| Zeldin Robert K Chief Medical Officer | 2019-12-20 17:03:41 | 380,325 0 | 380,325 | Form 4 |
| Macias William L. Chief Medical Officer | 2024-11-22 16:11:51 | 361,791 0 | 361,791 | Form 4 |
| Barnett Eva Renee Chief Financial Officer | 2024-11-22 16:09:49 | 331,169 0 | 331,169 | Form 4 |
| Levine Mark S. Chief Legal Officer | 2024-11-22 16:12:35 | 319,228 0 | 319,228 | Form 4 |
| Van Tuyl Christopher Chief Legal Officer | 2024-12-18 17:02:50 | 247,402 0 | 247,402 | Form 4 |
| Gloria Melanie Chief Operating Officer | 2024-11-20 17:15:40 | 247,402 0 | 247,402 | Form 4 |
| Yanchik Connealy Pamela Chief Financial Officer | 2021-03-23 08:45:16 | 208,200 0 | 208,200 | Form 4 |
| POTTER MYRTLE S Director | 2019-12-20 16:57:26 | 153,763 0 | 153,763 | Form 4 |
| MIDDLEKAUFF W BRADFORD General Counsel | 2020-05-18 08:28:15 | 142,600 0 | 142,600 | Form 4 |
| Stout Jay S Chief Technology Officer | 2024-10-25 16:21:39 | 142,186 0 | 142,186 | Form 4 |
| Geffner Michael Chief Medical Officer | 2024-10-25 16:23:41 | 134,971 0 | 134,971 | Form 4 |
| MIGAUSKY GEORGE V Director | 2024-04-04 16:48:19 | 125,753 0 | 125,753 | Form 4 |
| Hughes Douglas J. Director | 2024-12-04 16:20:16 | 119,585 0 | 119,585 | Form 4 |
| Pande Atul Director | 2024-12-04 16:22:39 | 86,663 20,000 | 106,663 | Form 4 |
| Fromkin Andrew J. Director | 2024-04-04 16:54:20 | 104,603 0 | 104,603 | Form 4 |
| SCHOENEBAUM MARK Director | 2019-05-09 21:21:45 | 0 20,000 | 20,000 | Form 3 |
| Nagendran Sukumar Director | 2019-05-09 21:21:14 | 0 20,000 | 20,000 | Form 3 |
| GRANADILLO PEDRO P Director | 2019-05-09 21:19:26 | 0 20,000 | 20,000 | Form 3 |
| Makker Gotham Director | 2019-05-09 21:18:48 | 0 20,000 | 20,000 | Form 3 |
| Health Sciences Holdings LLC 10% Owner | 2019-12-20 11:56:51 | 0 0 | 0 | Form 4 |
| Venker Eric Director | 2020-02-19 17:31:40 | 0 0 | 0 | Form 3 |
| Sirota Stephanie A VP of CSC | 2019-05-09 21:20:54 | 0 0 | 0 | Form 3 |
| Lee Alice VPO, Secretary and Treasurer | 2019-05-09 21:19:48 | 0 0 | 0 | Form 3 |
| Yalamanchi Naveen Vice President and CFO | 2019-05-09 21:19:06 | 0 0 | 0 | Form 3 |